The latest data from the government of the Democratic Republic of Congo revealed that the Ebola outbreak has resulted in the death of 2,325 individuals, surpassing the toll of the previous outbreak from 2018-2020 to become the deadliest in the country’s history. The country’s public health institute reported that the number of confirmed cases has now reached 4,945, with 101 new cases identified within the past 24 hours.
This outbreak, classified as the 17th in the country, has already broken records in terms of the highest number of cases. The total death toll has now exceeded the 2,299 fatalities recorded during the 2018-2020 outbreak, which was previously considered the worst in the country’s history. The current data also confirms 4,945 confirmed cases.
Three months since its official declaration, this outbreak is now second in scale only to the 2014-2016 Ebola outbreak in West Africa, where a total of 28,616 cases and 11,310 deaths were reported in Guinea, Liberia, and Sierra Leone. The rapid escalation of the current crisis is evident, as it took less than three months to reach 2,000 deaths, compared to nearly five months for the West Africa outbreak to reach 1,000 deaths.
The Ebola strain responsible for the current outbreak is the Bundibugyo species, for which there are no approved vaccines or treatments. The outbreak has intensified since its onset on May 15, facing challenges due to weak healthcare systems, community resistance, and ongoing instability hindering effective case identification and response efforts.
The case fatality ratio, indicating the percentage of confirmed cases resulting in death, has surged from about 20% in early June to 46%, signifying that nearly half of all confirmed cases are now fatal. Experts clarify that this spike does not suggest the virus has become more deadly but highlights ongoing deficiencies in surveillance, case detection, and access to proper care.
Efforts are underway to evaluate a limited number of experimental vaccines and therapies, while global health authorities explore the potential of existing Ebola treatments for protection. However, available evidence is currently restricted to animal studies.
The outbreak had previously spread to neighboring Uganda, where authorities successfully contained the situation, resulting in only two deaths and 20 confirmed cases before declaring an end to the outbreak in that country. Ebola transmission occurs through direct contact with bodily fluids of infected individuals, leading to symptoms such as fever, vomiting, diarrhea, and in severe cases, internal and external bleeding.
